A simple, robust and high-throughput LC-MS/MS method for the therapeutic drug monitoring of polymyxin B1, polymyxin B2, polymyxin B3, isoleucine-polymyxin B1, polymyxin E1 and polymyxin E2 in human plasma
- PMID: 39482854
- DOI: 10.1002/bmc.6034
A simple, robust and high-throughput LC-MS/MS method for the therapeutic drug monitoring of polymyxin B1, polymyxin B2, polymyxin B3, isoleucine-polymyxin B1, polymyxin E1 and polymyxin E2 in human plasma
Abstract
To facilitate clinical therapeutic drug monitoring (TDM) of polymyxin B (PB) and polymyxin E (PE), we developed and validated a simple LC-MS/MS method for simultaneous determination of PB (including polymyxin B1 (PB1), polymyxin B2 (PB2), polymyxin B3 (PB3) and isoleucine-polymyxin B1 (ile-PB1)) and PE (including polymyxin E1 (PE1) and polymyxin E2 (PE2)) in human plasma. PB or PE was extracted from 20.0 μL plasma using a 5% (v/v) formic acid acetonitrile solution and separated on a BEH-C18 column (2.1 × 100 mm, 1.7 μm) with a mobile phase consisting of 0.8% formic acid aqueous solution and 0.2% formic acid acetonitrile solution. Gradient elution was performed over 5.5 min at a flow rate of 0.250 mL/min. Quantitative analysis was conducted in positive ion scanning mode by electrospray ionization and multiple reaction monitoring. The method validation was conducted based on bioanalytical method validation guidance, including specificity, calibration curve, precision, accuracy, recovery, matrix effect, stability and dilution integrity and all of the results satisfied the requirements. The method was simple, robust and high-throughput and is currently being used to provide a TDM service to enhancing therapeutic efficacy and safety use of the PB and PE.
Keywords: LC–MS/MS; polymyxin B; polymyxin E; therapeutic drug monitoring.
© 2024 John Wiley & Sons Ltd.
References
REFERENCES
-
- Ainsworth, G. C., Brown, A. M., & Brownlee, G. (1947). Aerosporin, an antibiotic produced by Bacillus aerosporus Greer. Nature, 159(4060), 263. https://doi.org/10.1038/160263a0
-
- Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006). Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 50(6), 1953–1958. https://doi.org/10.1128/aac.00035-06
-
- Bihan, K., Lu, Q., Enjalbert, M., Apparuit, M., Langeron, O., Rouby, J. J., Funck‐Brentano, C., & Zahr, N. (2016). Determination of colistin and colistimethate levels in human plasma and urine by high‐performance liquid chromatography‐tandem mass spectrometry. Therapeutic Drug Monitoring, 38(6), 796–803. https://doi.org/10.1097/ftd.0000000000000345
-
- Burkin, M. A., Galvidis, I. A., Surovoy, Y. A., Plyushchenko, I. V., Rodin, I. A., & Tsarenko, S. V. (2021). Development of ELISA formats for polymyxin B monitoring in serum of critically ill patients. Journal of Pharmaceutical and Biomedical Analysis, 204, 114275. https://doi.org/10.1016/j.jpba.2021.114275
-
- Cao, G., Ali, F. E., Chiu, F., Zavascki, A. P., Nation, R. L., & Li, J. (2008). Development and validation of a reversed‐phase high‐performance liquid chromatography assay for polymyxin B in human plasma. The Journal of Antimicrobial Chemotherapy, 62(5), 1009–1014. https://doi.org/10.1093/jac/dkn343
MeSH terms
Substances
Grants and funding
- 2024JJ7347/Natural Science Foundation of Hunan Province, CN
- 2023JJ50447/Natural Science Foundation of Hunan Province, CN
- 2022M721543/Postdoctoral Science Foundation, CN
- 2021R3114/Science and Technology Plan Project of the Huaihua city, CN
- B202303018485/Health Commission Program of Hunan province, CN
LinkOut - more resources
Full Text Sources
Miscellaneous
